CD8+CD28− Treg suppressor function has been reported in normal healthy individuals [41] and patients with cancer [42], those who are undergoing transplantation (rejection free recipients) [43,44,45] or who have gastrointestinal [46] or autoimmune [31] conditions. This evidence concerns the gene CD8A and cancer.